Alexandria L. Fink

The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in <i>PIK3CA</i> -Mutant Breast Cancer Brain Metastases

Franziska M. Ippen, Christopher Alvarez‐Breckenridge, Benjamin M. Kuter et al. · Clinical Cancer Research · 2019 · 82 citations · Full text

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

Tareq A. Juratli, Devin McCabe, Naema Nayyar et al. · Acta Neuropathologica · 2018 · 80 citations

Mendelian Disorder, Poor Outcome, Dmd Genomic Deletions +6

Genotype-targeted local therapy of glioma

Ganesh M. Shankar, Ameya R. Kirtane, Julie J. Miller et al. · Proceedings of the National Academy of Sciences · 2018 · 53 citations · Full text

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Kensuke Tateishi, Taishi Nakamura, Tareq A. Juratli et al. · Clinical Cancer Research · 2019 · 46 citations · Full text

PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency–Mediated Acquired Resistance to Temozolomide

Fumi Higuchi, Alexandria L. Fink, Juri Kiyokawa et al. · Molecular Cancer Therapeutics · 2018 · 44 citations · Full text